Literature DB >> 27284491

Mutation profiles of synchronous colorectal cancers from a patient with Lynch syndrome suggest distinct oncogenic pathways.

Scott R Wheeler1, Chanjuan Shi1, Jonathan A Holt1, Cindy L Vnencak-Jones1.   

Abstract

Patients with Lynch syndrome often present with multiple synchronous or metachronous colorectal cancers (CRCs). The presence of multiple CRCs with distinct genetic profiles and driver mutations could complicate treatment as each cancer may respond differently to therapy. Studies of sporadic CRCs suggested that synchronous tumors have distinct etiologies, but could not rule out differences in genetic background. The presence of multiple cancers in a patient with a predisposing mutation provides an opportunity to profile synchronous cancers in the same genetic background. Here, we describe the case of a patient with Lynch syndrome that presented with six synchronous CRCs. Microsatellite instability (MSI) and genomic profiling indicated that each lesion had a unique pattern of instability and a distinct profile of affected genes. These findings support the idea that in Lynch syndrome, synchronous CRCs can develop in parallel with distinct mutation profiles and that these differences may inform treatment decisions.

Entities:  

Keywords:  Colorectal neoplasms; hereditary nonpolyposis; medical oncology; molecular targeted therapy; multiple primary; neoplasms

Year:  2016        PMID: 27284491      PMCID: PMC4880766          DOI: 10.21037/jgo.2016.01.07

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  19 in total

1.  Targeted therapies in colorectal cancer: surgical considerations.

Authors:  Carrie Luu; Amanda K Arrington; Hans F Schoellhammer; Gagandeep Singh; Joseph Kim
Journal:  J Gastrointest Oncol       Date:  2013-09

Review 2.  SWI/SNF nucleosome remodellers and cancer.

Authors:  Boris G Wilson; Charles W M Roberts
Journal:  Nat Rev Cancer       Date:  2011-06-09       Impact factor: 60.716

3.  Clinicopathological significance of synchronous carcinoma in colorectal cancer.

Authors:  Alfred King-Yin Lam; Robert Carmichael; Petra Gertraud Buettner; Vinod Gopalan; Yik-Hong Ho; Simon Siu
Journal:  Am J Surg       Date:  2011-05-19       Impact factor: 2.565

4.  Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors.

Authors:  Jeong M Bae; Nam-Yun Cho; Tae-You Kim; Gyeong H Kang
Journal:  Dis Colon Rectum       Date:  2012-02       Impact factor: 4.585

5.  MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis.

Authors:  Y Wu; M Nyström-Lahti; J Osinga; M W Looman; P Peltomäki; L A Aaltonen; A de la Chapelle; R M Hofstra; C H Buys
Journal:  Genes Chromosomes Cancer       Date:  1997-04       Impact factor: 5.006

6.  Epidemiology and prognosis of synchronous colorectal cancers.

Authors:  M Latournerie; V Jooste; V Cottet; C Lepage; J Faivre; A-M Bouvier
Journal:  Br J Surg       Date:  2008-12       Impact factor: 6.939

7.  Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.

Authors:  Allison M Cushman-Vokoun; Daniel G Stover; Zhiguo Zhao; Elizabeth A Koehler; Jordan D Berlin; Cindy L Vnencak-Jones
Journal:  Clin Colorectal Cancer       Date:  2013-06-14       Impact factor: 4.481

8.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

9.  ClinVar: public archive of relationships among sequence variation and human phenotype.

Authors:  Melissa J Landrum; Jennifer M Lee; George R Riley; Wonhee Jang; Wendy S Rubinstein; Deanna M Church; Donna R Maglott
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

10.  Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.

Authors:  Kaidi Mikhitarian; Maressa Pollen; Zhiguo Zhao; Yu Shyr; Nipun B Merchant; Alexander Parikh; Frank Revetta; M Kay Washington; Cindy Vnencak-Jones; Chanjuan Shi
Journal:  Mod Pathol       Date:  2013-11-01       Impact factor: 7.842

View more
  4 in total

1.  Genomic analysis of synchronous intracranial meningiomas with different histological grades.

Authors:  Tamrin Chowdhury; Yongjin Yoo; Youngbeom Seo; Yun-Sik Dho; Sojin Kim; Anna Choi; Murim Choi; Sung-Hye Park; Chul-Kee Park; Sang Hyung Lee; Ji Yeoun Lee
Journal:  J Neurooncol       Date:  2018-02-08       Impact factor: 4.130

Review 2.  Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes.

Authors:  Nayiri M Kaissarian; Douglas Meyer; Chava Kimchi-Sarfaty
Journal:  J Natl Cancer Inst       Date:  2022-08-08       Impact factor: 11.816

Review 3.  Recent progress in Lynch syndrome and other familial colorectal cancer syndromes.

Authors:  Patrick M Boland; Matthew B Yurgelun; C Richard Boland
Journal:  CA Cancer J Clin       Date:  2018-02-27       Impact factor: 508.702

4.  Acquired somatic TP53 or PIK3CA mutations are potential predictors of when polyps evolve into colorectal cancer.

Authors:  Pi-Yueh Chang; Jinn-Shiun Chen; Shih-Cheng Chang; Mei-Chia Wang; Nai-Chung Chang; Ying-Hao Wen; Wen-Sy Tsai; Wei-Hsiu Liu; Hsiu-Ling Liu; Jang-Jih Lu
Journal:  Oncotarget       Date:  2017-08-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.